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Dear editor
We read with great interest the original work by Murphy et al analyzing the effects 
of two treatment strategies for delivery of noninvasive mechanical ventilation in 
hypercapnic patients with chronic obstructive pulmonary disease.1 High pressure 
and high intensity noninvasive mechanical ventilation were compared in a short-term 
crossover trial to assess whether high intensity noninvasive mechanical ventilation 
(inspiratory pressure  25 cm H
2
O associated with a high backup ventilator rate) 
may improve adherence, physiological, and subjective outcomes when compared with 
delivery of high pressure noninvasive mechanical ventilation (without elevated backup 
respiratory rate). The authors concluded that both strategies are equivalent in all the 
recorded outcomes, showing thus that driving pressure, but not backup respiratory 
rate, is essential to gain physiological and clinical benefits in this population when in 
a chronic stable condition.
Despite previous randomized studies showing the potential benefits of long-term 
noninvasive mechanical ventilation in hypercapnic patients with chronic obstructive 
pulmonary disease, current research has still not clearly indicated the best strategy to 
improve the patient’s adherence with treatment.2,3 Overall, dropout during noninvasive 
mechanical ventilation remains a serious clinical problem.4 This study provides 
valuable information in this regard, suggesting that sufficiently high-pressure delivery 
is enough to achieve useful clinical and physiological goals.
This notwithstanding, we believe that some of the expectations following the 
adoption of these different noninvasive mechanical ventilation strategies have not 
been adequately addressed in the present study. Therefore, we consider that it would 
be useful, from a practical point of view, to underline some points in this regard.
First, the authors did not determine what effects the highest respiratory backup 
rate used in their study may have had. Although there have been no major studies 
published on application of high levels of backup that have proved to be useful in 
patients with severe chronic obstructive pulmonary disease, this is the best indication 
for hypoventilation syndromes, ie, obesity and overlap syndromes. In fact, we cannot 
exclude that addition of a high backup respiratory rate may help to resolve “overlap” 
when present at a subclinical level in patients with chronic obstructive pulmonary 
disease, or that it has not been adequately assessed before. However, it seems that 
the authors selected backup respiratory rate levels on a clinical basis without any 
physiological assessment in their study population. Despite patients in the present 
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study not appearing to show any abnormal increase in their 
body mass index, the extrapolated conclusion of a lack of 
additional benefit from a well assessed strategy, including 
adequate backup respiratory rate, cannot be firmly excluded 
in such “extreme” cases.5
Second, there was a lack of complementary tests in 
this study that might have helped in analysis of the data. 
Indeed, the authors selected patients with a FEV
1
 (forced 
expiratory volume in one second) that could worsen with high 
backup and pressure, especially with the auto-positive end-
expiratory pressure mechanism. It is not clear how selection 
of expiratory-positive airway pressure was made in the study 
population. Similarly, the authors did not take into account 
any potential auto-positive end-expiratory pressure effects 
during the 6-week period of observation.
Third, the authors arbitrarily selected a population of 
hypercapnic patients with chronic obstructive pulmonary 
disease (daytime PaCO
2
  6 kPa) which would not be 
universally recognized as the most appropriate in terms of 
risk of frequency of exacerbations and clinical instability, and 
it is not clear whether any other additional clinical factors 
behind cardiac dysfunction may have interfered at admission 
or over the study period.6 Indeed, three of the five patients 
who withdrew did so because of factors other than mere 
mask/pressure intolerance (see Table E1).1
Final, there was no analysis of potential implications of 
air leakage in the observed results. No mention was made 
of measurement or monitoring of leakage during application 
of noninvasive mechanical ventilation. This aspect could 
have been potentially relevant and interfered with the results, 
especially during application of such high-pressure delivery, 
which is known to increase mask leakages.4
To conclude, we recognize that the paper by Murphy et al1 
will add information to the complex process of setting 
and titration of noninvasive mechanical ventilation in the 
population of stable hypercapnic patients with chronic 
obstructive pulmonary disease. However, given the 
observations discussed, we are convinced that further 
studies of longer duration and including larger numbers 
of patients are needed to determine which physiological 
effects should be assessed and expected during application 
of both strategies. Currently, high-pressure strategies remain 
a “double edged sword” in daily practice.
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Dear editor
We thank Esquinas et al for their thoughtful comments 
on our recent published trial. We acknowledge that the set 
backup rate in the high-intensity group was determined 
clinically. However, the low triggering rate recorded in the 
high-intensity arm indicates that these patients were largely 
in mandatory ventilation, ie, by definition, they received 
high-intensity ventilation. Further, we consider that the 
high backup rate would be expected to contribute further to 
intrinsic positive end-expiratory pressure because the lung 
emptying at the end of expiration would be incomplete as 
the ventilator cycles from expiration to inspiration early, 
which would contribute greater patient-ventilator asynchrony. 
Patients with obstructive sleep apnea and/or obesity hypoven-
tilation syndrome were excluded from the study because this 
is the group most likely to benefit from addition of a backup 
rate, a point highlighted by Esquinas et al. In a post hoc 
analysis of another recently published trial, a backup rate of 
14 breaths per minute in obese patients was more important 
in controlling nocturnal hypoventilation than the mode of 
ventilation per se.1
The expiratory-positive airway pressure setting in the 
study was selected according to the ventilation setup algo-
rithm provided in Figure E1.2 The major clinical drive to 
undertake this trial was a physiological concern that use of 
high-intensity noninvasive mechanical ventilation in chronic 
obstructive pulmonary disease would exacerbate intrinsic 
positive end-expiratory pressure and subsequently have an 
adverse effect on outcome. Although the high-intensity mode 
has been shown to provide superior control of nocturnal 
hypoventilation compared with the low-intensity mode,3 it has 
not been compared with a high-pressure strategy alone until 
the current published trial. The authors considered that this 
would have a lesser impact on patient-ventilator asynchrony, 
although we acknowledge that we did not make detailed 
physiological measurements in this randomized, controlled 
clinical trial. However, the expected adverse clinical impact 
of intrinsic positive end-expiratory pressure would be a 
worsening of patient-ventilator synchrony, and this would 
be reflected in a reduction in patient subjective or objective 
assessment of sleep, recorded in the study by visual analog 
score and actigraphy, respectively. Neither marker indicated 
a treatment effect in the current study. The earlier work by 
Dreher et al, which compared a high-intensity versus low-
intensity approach, again failed to show a difference in sub-
jective or objective sleep during application of noninvasive 
mechanical ventilation.4
Earlier work using low-pressure strategies has failed to 
demonstrate unequivocally a clinical benefit of noninvasive 
mechanical ventilation in hypercapnic chronic obstructive 
pulmonary disease and, as such, there is debate as to the 
phenotype of patient that will benefit most from domiciliary 
noninvasive mechanical ventilation. Thus, the current 
inclusion criteria are to some extent arbitrary, and the 
selection of patients was clearly described in the methods. 
Currently, there is a great deal of interest in which patients 
benefit most from domiciliary noninvasive mechanical 
ventilation, and this is the focus of ongoing European trials 
(HoT-HMV UK, NCT00990132, NCT00710541). On a 
related point, we agree with Esquinas et al that patients with 
chronic obstructive pulmonary disease and a significantly 
elevated PaCO
2
 are most likely to benefit, as was shown in the 
current trial, given that the mean PaCO
2
 was 8.5 ± 1.8 kPa.
Finally, measurements of air leak were not performed 
in the current trial, and addition of these data could have 
enhanced the paper and provided useful information for the 
clinician when applying the study conclusions in clinical 
practice. The authors acknowledge that ventilator settings 
and higher pressure may well be associated with higher levels 
of leak and that these may interfere with patient-ventilator 
synchrony and thus adherence with noninvasive mechanical 
ventilation.5
The data from the current study add to the previously 
published data to allow the clinician greater scope in the 
management of these complex and challenging patients. 
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In essence, control of nocturnal hypoventilation should be 
the therapeutic goal of noninvasive mechanical ventilation 
in chronic obstructive pulmonary disease. The ventilation 
strategy requires a personalized approach that is modeled for 
the individual patient and, as such, the clinician must always 
remember that there is “more than one way to skin a cat”.
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